BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 20603237)

  • 21. Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma.
    Moss TJ; Reynolds CP; Sather HN; Romansky SG; Hammond GD; Seeger RC
    N Engl J Med; 1991 Jan; 324(4):219-26. PubMed ID: 1985243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of markers of possible prognostic value in 57 giant cell tumors of bone.
    Gamberi G; Serra M; Ragazzini P; Magagnoli G; Pazzaglia L; Ponticelli F; Ferrari C; Zanasi M; Bertoni F; Picci P; Benassi MS
    Oncol Rep; 2003; 10(2):351-6. PubMed ID: 12579271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin-like growth factor-I receptor expression regulates neuroblastoma metastasis to bone.
    van Golen CM; Schwab TS; Kim B; Soules ME; Su Oh S; Fung K; van Golen KL; Feldman EL
    Cancer Res; 2006 Jul; 66(13):6570-8. PubMed ID: 16818629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dickkopf-1 autoantibody is a novel serological biomarker for non-small cell lung cancer.
    Yao X; Jiang H; Zhang C; Wang H; Yang L; Yu Y; Yu J; Shi B; Shen Z; Gao H; Chen Z; Tian S; Lu S; Li Z; Gu J
    Biomarkers; 2010 Mar; 15(2):128-34. PubMed ID: 19839718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
    Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
    Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased serum Dickkopf-1 levels in drug-abusing psychotic patients.
    Serata D; Kotzalidis GD; Riozzi B; Storto M; Panaccione I; Romano S; Rapinesi C; Porfiri GM; Casolla B; Del Casale A; Curto M; Caloro M; Girardi N; Savoja V; Nicoletti F; Tatarelli R; Girardi P
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):239-44. PubMed ID: 22122879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lung cancer-derived Dickkopf1 is associated with bone metastasis and the mechanism involves the inhibition of osteoblast differentiation.
    Chu T; Teng J; Jiang L; Zhong H; Han B
    Biochem Biophys Res Commun; 2014 Jan; 443(3):962-8. PubMed ID: 24361889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse outcome of infants with metastatic neuroblastoma, MYCN amplification and/or bone lesions: results of the French society of pediatric oncology.
    Minard V; Hartmann O; Peyroulet MC; Michon J; Coze C; Defachelle AS; Lejars O; Perel Y; Bergeron C; Boutard P; Leverger G; Stephan JL; Thyss A; Chastagner P; Couillault G; Devalck C; Lutz P; Mechinaud F; Millot F; Plantaz D; Rialland X; Rubie H
    Br J Cancer; 2000 Oct; 83(8):973-9. PubMed ID: 10993641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MMP-2, MMP-9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone.
    Incorvaia L; Badalamenti G; Rini G; Arcara C; Fricano S; Sferrazza C; Di Trapani D; Gebbia N; Leto G
    Anticancer Res; 2007; 27(3B):1519-25. PubMed ID: 17595770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid.
    Coleman RE; Major P; Lipton A; Brown JE; Lee KA; Smith M; Saad F; Zheng M; Hei YJ; Seaman J; Cook R
    J Clin Oncol; 2005 Aug; 23(22):4925-35. PubMed ID: 15983391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum bone sialoprotein levels and bone metastases.
    Uccello M; Malaguarnera G; Vacante M; Motta M
    J Cancer Res Ther; 2011; 7(2):115-9. PubMed ID: 21768695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
    Pollmann D; Siepmann S; Geppert R; Wernecke KD; Possinger K; Lüftner D
    Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple target molecular monitoring of bone marrow and peripheral blood samples from patients with localized neuroblastoma and healthy donors.
    Corrias MV; Haupt R; Carlini B; Cappelli E; Giardino S; Tripodi G; Tonini GP; Garaventa A; Pistoia V; Pistorio A
    Pediatr Blood Cancer; 2012 Jan; 58(1):43-9. PubMed ID: 21254375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The use of neuron specific enolase in the prognosis and followup of neuroblastoma in children. Results of a retrospective series of 21 patients].
    Abdennebi M; Boussen H; Harzallah L; Daldoul O; Ghanem A; Gamoudi A; Ben Slimene F; Rahal K; el May A; Ben Ayed F; Guemira F
    Tunis Med; 2000 Feb; 78(2):106-8. PubMed ID: 10894045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prognostic value of serum chromogranin A and prostate specific antigen in prostate cancer patients for progression to the hormone resistance state.
    Zissimopoulos A; Bantis A; Sountoulides P; Giannakopoulos S; Kalaitzis C; Agelonidou E; Touloupidis S
    Hell J Nucl Med; 2009; 12(3):234-7. PubMed ID: 19936334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification.
    Krams M; Hero B; Berthold F; Parwaresch R; Harms D; Rudolph P
    Cancer; 2002 Feb; 94(3):854-61. PubMed ID: 11857322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A crosstalk between myeloma cells and marrow stromal cells stimulates production of DKK1 and interleukin-6: a potential role in the development of lytic bone disease and tumor progression in multiple myeloma.
    Gunn WG; Conley A; Deininger L; Olson SD; Prockop DJ; Gregory CA
    Stem Cells; 2006 Apr; 24(4):986-91. PubMed ID: 16293576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The morphological assessment of bone marrow infiltration in neuroblastoma].
    Brisigotti M; Medicina D; Bercich L; Bonetti MF; Fabbretti G; Gambini C; Lo Piccolo MS; Milanaccio C; Rosanda C; Garaventa A; De Bernardi B; Callea F
    Pediatr Med Chir; 1998; 20(3):169-74. PubMed ID: 9744007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating cathepsin K and cystatin C in patients with cancer related bone disease: clinical and therapeutic implications.
    Tumminello FM; Flandina C; Crescimanno M; Leto G
    Biomed Pharmacother; 2008 Feb; 62(2):130-5. PubMed ID: 17728092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased Dickkopf-1 expression accelerates bone cell apoptosis in femoral head osteonecrosis.
    Ko JY; Wang FS; Wang CJ; Wong T; Chou WY; Tseng SL
    Bone; 2010 Mar; 46(3):584-91. PubMed ID: 19895917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.